Worldwide: Healthcare

On July 29, 2026, Health Canada announced that it had obtained a permanent injunction against a Québec-based company in connection with the sale of unauthorized injectable peptides in Canada. The announcement reflects Health Canada’s continued focus on peptide products and serves as a reminder that injectable peptides intended for human use are regulated as prescription drugs and are subject to Canada's drug regulatory framework.

Health Canada appears to be administratively reclassifying Class I Medical Devices as Class II based solely on product claims rather than the established Classification Rules that focus...

Health Canada has launched a new public search portal for clinical trials authorized in Canada, alongside updated guidance documents for sponsors and applicants. The portal enhances transparency by making information about authorized clinical trials more readily accessible to patients, researchers, and industry stakeholders, while the updated guidance clarifies expectations for trial registration, summary results reporting, and public disclosure.

The Omnipod insulin pump system, a widely-used device for diabetes management, faces serious medical device recalls due to manufacturing defects that can compromise insulin delivery. These defects may lead to severe health complications including hyperglycemia and diabetic ketoacidosis, prompting legal investigations into potential claims against manufacturer Insulet Corporation. Canadian users of the recalled devices who have experienced serious health issues are urged to seek legal consultation regarding

Le 15 juillet 2026, l'Arrêté prévoyant le recours à des décisions d'autorités réglementaires étrangères de la ministre de la Santé est entré en vigueur, permettant à Santé Canada de s'appuyer sur des décisions d'autorités réglementaires étrangères de confiance pour accélérer l'examen des présentations de drogues.

On June 17, 2026, Health Canada published the Regulations Amending Certain Regulations Made Under the Food and Drugs Act (Shortages and Discontinuation of Sale of Drugs and Medical Devices) (the “Amending Regulations”), introducing amendments to the Food and Drug Regulations (“FDR”) and the Medical Devices Regulations (“MDR”).

Osler's Legislative Update is a bi-weekly listing of new legislation. This issue covers legislation for the period 06/19 to 07/08.

La 56e édition des Journées dentaires internationales du Québec se tiendra au Palais des congrès de Montréal, du 29 mai au 2 juin 2026.

Google is venturing into new territory with the development of the Fitbit Air, marking a significant evolution in wearable health technology. This advancement represents Google's continued commitment to integrating sophisticated health monitoring capabilities into consumer devices. What innovations will this next-generation wearable bring to the competitive health tech market?